237 related articles for article (PubMed ID: 19643519)
1. Emerging therapies for patients with advanced chronic lymphocytic leukaemia.
Delgado J; Briones J; Sierra J
Blood Rev; 2009 Sep; 23(5):217-24. PubMed ID: 19643519
[TBL] [Abstract][Full Text] [Related]
2. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Hematol Oncol; 2005 Mar; 23(1):34-40. PubMed ID: 16149106
[TBL] [Abstract][Full Text] [Related]
3. Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.
Del Poeta G; Ilaria Del Principe M; Buccisano F; Maurillo L; Niscola P; Venditti A; Amadori S
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1787-800. PubMed ID: 17181492
[TBL] [Abstract][Full Text] [Related]
4. Flavopiridol in chronic lymphocytic leukemia: a concise review.
Christian BA; Grever MR; Byrd JC; Lin TS
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S179-85. PubMed ID: 19778838
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic lymphocytic leukemia.
Faderl SJ; Keating MJ
Curr Hematol Rep; 2005 Jan; 4(1):31-8. PubMed ID: 15610657
[TBL] [Abstract][Full Text] [Related]
6. Novel therapies for chronic lymphocytic leukemia in the 21st century.
Byrd JC; Waselenko JK; Keating M; Rai K; Grever MR
Semin Oncol; 2000 Oct; 27(5):587-97. PubMed ID: 11049025
[TBL] [Abstract][Full Text] [Related]
7. Management of advanced chronic lymphocytic leukemia.
Cao TM; Coutre SE
Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies in chronic lymphocytic leukemia.
Ferrajoli A; Faderl S; Keating MJ
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1231-8. PubMed ID: 17020457
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapy for chronic lymphocytic leukaemia.
Auer RL; Gribben J; Cotter FE
Br J Haematol; 2007 Dec; 139(5):635-44. PubMed ID: 17961187
[TBL] [Abstract][Full Text] [Related]
10. High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.
Dungarwalla M; Evans SO; Riley U; Catovsky D; Dearden CE; Matutes E
Haematologica; 2008 Mar; 93(3):475-6. PubMed ID: 18310545
[TBL] [Abstract][Full Text] [Related]
11. Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL.
Klepfish A; Rachmilewitz EA; Kotsianidis I; Patchenko P; Schattner A
QJM; 2008 Sep; 101(9):737-40. PubMed ID: 18650226
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukemia: recent advances in diagnosis and treatment.
Abbott BL
Oncologist; 2006 Jan; 11(1):21-30. PubMed ID: 16401710
[TBL] [Abstract][Full Text] [Related]
13. Initial therapy for patients with chronic lymphocytic leukemia.
Wierda WG; O'Brien SM
Semin Oncol; 2006 Apr; 33(2):202-9. PubMed ID: 16616067
[TBL] [Abstract][Full Text] [Related]
14. Novel agents and strategies for treatment of p53-defective chronic lymphocytic leukemia.
Grever MR; Lucas DM; Johnson AJ; Byrd JC
Best Pract Res Clin Haematol; 2007 Sep; 20(3):545-56. PubMed ID: 17707839
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
16. Controversies in the front-line management of chronic lymphocytic leukemia.
Nabhan C; Shanafelt TD; Kay NE
Leuk Res; 2008 May; 32(5):679-88. PubMed ID: 18191201
[TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients.
Tam CS; Otero-Palacios J; Abruzzo LV; Jorgensen JL; Ferrajoli A; Wierda WG; Lerner S; O'Brien S; Keating MJ
Br J Haematol; 2008 Apr; 141(1):36-40. PubMed ID: 18324964
[TBL] [Abstract][Full Text] [Related]
18. Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?
Bruserud Ø; Tronstad KJ; McCormack E; Gjertsen BT
Cancer Immunol Immunother; 2006 Feb; 55(2):221-8. PubMed ID: 16034559
[TBL] [Abstract][Full Text] [Related]
19. [Advances in the treatment of chronic lymphocytic leukaemia].
Mozas P; Delgado J
Med Clin (Barc); 2016 Nov; 147(10):447-454. PubMed ID: 27431885
[TBL] [Abstract][Full Text] [Related]
20. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
Kharfan-Dabaja MA; Chavez JC; Khorfan KA; Pinilla-Ibarz J
Cancer; 2008 Sep; 113(5):897-906. PubMed ID: 18618518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
